Physically Active During Cancer Treatment (FAKT)
FAKT
1 other identifier
interventional
66
1 country
5
Brief Summary
This randomized controlled trial aims to investigate whether an individually tailored exercise program and nutritional guide can affect the development of self-reported peripheral sensory neuropathy and fatigue in patients with colorectal cancer receiving adjuvant chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2019
CompletedFirst Posted
Study publicly available on registry
March 22, 2019
CompletedStudy Start
First participant enrolled
March 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
ExpectedJune 5, 2025
June 1, 2025
3.5 years
February 6, 2019
June 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient reported peripheral sensory neuropathy
The 9-item European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) Chemotherapy Induced Peripheral Neuropathy (CIPN20) sensory subscale will be used to measure sensory neuropathy. Each item is rated on a scale from 1 ("not at all") to 4 ("very much"), and the total raw score ranges from 9 to 36. The raw scores will be linearly transformed to a 0 to 100 scale (higher scores represent worse CIPN severity).
Baseline to 3 months
Secondary Outcomes (27)
Fatigue
Baseline to 3, 6, 9, 12, 24 and 36 months
Change in patient reported peripheral sensory neuropathy.
Baseline to 3, 6, 9, 12, 24 and 36 months
Change in patient reported motor neuropathy
Baseline to 3, 6, 9, 12, 24 and 36 months
Change in patient reported autonomic neuropathy
Baseline to 3, 6, 9, 12, 24 and 36 months
Clinicians reported neuropathy
Baseline to 3, 6 and 12 months.
- +22 more secondary outcomes
Other Outcomes (4)
Serious adverse events (SAE)
Baseline to 6 months
Patient's expectations and experiences
Baseline, 3 and 6 months
Medical treatment for hypertension.
Baseline, 3, 6 and 12 months
- +1 more other outcomes
Study Arms (2)
Exercise training and nutritional guide
EXPERIMENTALStandard recommendations regarding physical activity and nutrition. An individually tailored exercise program and nutritional guide during adjuvant chemotherapy.
Standard follow-up care
ACTIVE COMPARATORStandard recommendations regarding physical activity and nutrition.
Interventions
30 minutes of a combination of sensorimotor- and strength training guided by a physical therapist twice a week. In addition 90 minutes a week of moderate intensity aerobic training or 45 minutes a week of high intensity aerobic training. Once a month the participants will fill out the form, PG-SGA SF, and he or she will be referred to a nutritionist if the score is 2 or higher. The intervention period lasts as long as the participants receives adjuvant chemotherapy, i.e. 3 - 6 months.
standard recommendations regarding physical activity and nutrition during the period with adjuvant chemotherapy.
Eligibility Criteria
You may qualify if:
- Radical resection for colon- or rectal cancer past 3 months, and scheduled for adjuvant, Oxaliplatin-based, combination chemotherapy.
- Histologically confirmed adenocarcinoma.
- Able to read and understand Norwegian.
- Able to carry out the intervention.
- Performance Status (PS) 0 - 2.
You may not qualify if:
- Serious comorbidities that contraindicate physical exercise, based on the treating physician's assessment.
- Unable to give informed consent.
- Prior treatment with Oxaliplatin
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Olavs Hospitallead
- Alesund Hospitalcollaborator
- Helse Nord-Trøndelag HFcollaborator
- Ullevaal University Hospitalcollaborator
- Sorlandet Hospital HFcollaborator
- Asker & Baerum Hospitalcollaborator
- Haukeland University Hospitalcollaborator
Study Sites (5)
Ålesund sjukehus
Ålesund, Norway
Sørlandet sykehus, Kristiansand
Kristiansand, Norway
Levanger sykehus
Levanger, Norway
Ullevål
Oslo, Norway
Kreftklinikken, St Olavs Hospital
Trondheim, Norway
Related Publications (1)
Hatlevoll I, Oldervoll LM, Wibe A, Stene GB, Stafne SN, Hofsli E. Physical exercise during adjuvant chemotherapy for colorectal cancer-a non-randomized feasibility study. Support Care Cancer. 2021 Jun;29(6):2993-3008. doi: 10.1007/s00520-020-05789-z. Epub 2020 Oct 8.
PMID: 33030598DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Arne Solberg, md phd
St. Olavs Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2019
First Posted
March 22, 2019
Study Start
March 27, 2019
Primary Completion
September 13, 2022
Study Completion (Estimated)
June 1, 2027
Last Updated
June 5, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share